WINDTREE THERAPEUTICS INC /DE/ Deferred Revenue Recognized
WINDTREE THERAPEUTICS INC /DE/ (WINT) reported Deferred Revenue Recognized of $198.00 thousand for the 12-month period ending 2019-12-31, per its 10-K filed 2021-03-29.
Discontinued › Income Statement › Other Income
us-gaap:ContractWithCustomerLiabilityRevenueRecognized · last filed 2021-03-29
- WINDTREE THERAPEUTICS INC /DE/ contract with customer, liability, revenue recognized for the quarter ending 2019-03-31 was $40.00K, a 80.39% decline year-over-year.
- WINDTREE THERAPEUTICS INC /DE/ contract with customer, liability, revenue recognized for the quarter ending 2018-03-31 was $204.00K.
- WINDTREE THERAPEUTICS INC /DE/ contract with customer, liability, revenue recognized for fiscal 2019 was $198.00K, a 81.88% decline from fiscal 2018.
- WINDTREE THERAPEUTICS INC /DE/ contract with customer, liability, revenue recognized for fiscal 2018 was $1.09M.
| Period end | Contract with Customer, Liability, Revenue Recognized 3 month | Contract with Customer, Liability, Revenue Recognized 6 month | Contract with Customer, Liability, Revenue Recognized 9 month | Contract with Customer, Liability, Revenue Recognized 12 month |
|---|---|---|---|---|
| 2019-12-31 | $198.00K 10-K · filed 2021-03-29 | |||
| 2019-09-30 | $198.00K 10-Q · filed 2020-11-16 | |||
| 2019-06-30 | $198.00K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $40.00K 10-Q · filed 2020-05-13 | |||
| 2018-12-31 | $1.09M 10-K · filed 2020-04-03 | |||
| 2018-09-30 | $789.00K 10-Q · filed 2019-11-14 | |||
| 2018-06-30 | $560.00K 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $204.00K 10-Q · filed 2019-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |